Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Abstract Current classes of cancer therapeutics have negative side effects stemming from off-target cytotoxicity. One way to avoid this would be to use a drug delivery system decorated with targeting moieties, such as an aptamer, if a targeted aptamer is available. In this study, aptamers were selec...
Guardado en:
Autores principales: | Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan, Mark Wunderlich, Bahareh Hosseinpour, Bianca S. Bono, Melissa J. Chee, James C. Mulloy, William G. Willmore, Maria C. DeRosa, Edward J. Merino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/17d8b5d0007c474daed087ef61f4e1db |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA aptamer evolved by cell-SELEX for recognition of prostate cancer.
por: Yuanyuan Wang, et al.
Publicado: (2014) -
Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX
por: Guodong Wang, et al.
Publicado: (2017) -
MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
por: Xinyue Chen, et al.
Publicado: (2019) -
Selection of aptamers for mature white adipocytes by cell SELEX using flow cytometry.
por: Eun Young Kim, et al.
Publicado: (2014) -
Publisher Correction: MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors
por: Xinyue Chen, et al.
Publicado: (2020)